Have a personal or library account? Click to login
Epidemiological Characteristics and Prospective 6-Months Follow-up of Children with Pulmonary Arterial Hypertension Cover

Epidemiological Characteristics and Prospective 6-Months Follow-up of Children with Pulmonary Arterial Hypertension

Acta Marisiensis - Seria Medica
Volume 61 (2015): Issue 2 (June 2015)
By:
Open Access
|Aug 2015

References

  1. 1. Georg Hansmann, Marius M. Hoeper. Registries for paediatric pulmonary hypertension. Eur Respir J. 2013;42:580-583.10.1183/09031936.00065713
    Search in Google Scholar
  2. 2. Fraisse A, Jais X, Schleich JM, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. 2010;103:66-74.10.1016/j.acvd.2009.12.001
    Search in Google Scholar
  3. 3. Modelina S, Hislop AA, Foster H, et al. Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart. 2010;96:1401-1406.10.1136/hrt.2009.182378
    Search in Google Scholar
  4. 4. von Loon RL, Roofthooft MT, Hillege HL, et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation. 2011;124:1755-1764.10.1161/CIRCULATIONAHA.110.969584
    Search in Google Scholar
  5. 5. Ivy D, Abam SH, Barst RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol. 2013;62 Suppl:D118-27.
    Search in Google Scholar
  6. 6. Barst RJ, McGoon MD, Elliot CG, et al. Survival in childhood pulmonary arterial hypertension insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012;125:113-122.10.1161/CIRCULATIONAHA.111.026591
    Search in Google Scholar
  7. 7. Berger RM, Beghetti M, Humpl T, et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet. 2012;379:537-546.10.1016/S0140-6736(11)61621-8
    Search in Google Scholar
  8. 8. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association. I Am Coll Cardiol. 2009;53:1573-1619.10.1016/j.jacc.2009.01.00419389575
    Search in Google Scholar
  9. 9. Douwers JM, van Loon RL, Hoendermis ES, et al. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J. 2011;32:3137-3146.10.1093/eurheartj/ehr28221893489
    Search in Google Scholar
  10. 10. Ivy DD, Rosenzweig EB, Lemarie JC, et al. Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. Am J Cardiol. 2010;106:1332-1338.10.1016/j.amjcard.2010.06.064296687421029834
    Search in Google Scholar
  11. 11. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension, Eur Heart J, 2009, 30:2493-2537.
    Search in Google Scholar
  12. 12. Peacock AJ, Murphy NF, McMurray, et al. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104-109.10.1183/09031936.0009230617360728
    Search in Google Scholar
  13. 13. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-1030.10.1164/rccm.200510-1668OC
    Search in Google Scholar
  14. 14. McLaughlin VV, Gaine SP, Howard LS, et al. Treatment goals of Pulmonary Hypertension. JACC. 2013;62,Suppl D, D73-81.
    Search in Google Scholar
  15. 15. Galie N, Rubin M, Hoeper M, et al. Tretment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomized controlled trial. Lancet. 2008;371:2093-2100.10.1016/S0140-6736(08)60919-8
    Search in Google Scholar
  16. 16. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161:487-492.10.1164/ajrccm.161.2.9906015
    Search in Google Scholar
  17. 17. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002;40:780-788.10.1016/S0735-1097(02)02012-0
    Search in Google Scholar
  18. 18. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164-172.10.1161/CIRCULATIONAHA.109.898122
    Search in Google Scholar
  19. 19. Vonk MC, Sander MH, van den Hoogen, et al. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue disease. Eur J Echocardiogr. 2007;8:317-321.10.1016/j.euje.2006.06.002
    Search in Google Scholar
  20. 20. Şuteu Carmen, Făgărăşan Amalia, Muntean Iolanda, et al. Parameters for the assessment of pulmonary vasodilator therapy in pulmonary arterial hypertension in children. Acta Medical Marisiensis. 2012;58(6):462-466.
    Search in Google Scholar
  21. 21. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034-1041.10.1164/rccm.200604-547OC
    Search in Google Scholar
  22. 22. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll, Cardiol. 2002;39:1214-1219.10.1016/S0735-1097(02)01744-8
    Search in Google Scholar
  23. 23. Bustamante-Labarta M, Perrone S, De La Fuerte RL, et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. J Am Soc Echocardiogr. 2002;15:1160-1164.10.1067/mje.2002.12396212411899
    Search in Google Scholar
  24. 24. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler echocardiography and cardiac catheterisation correlates of survival in primary pulmonary hypertension. Circulation. 1989;80:353-360.10.1161/01.CIR.80.2.3532752562
    Search in Google Scholar
  25. 25. Bossone E, D`Andrea A, D`Alto M, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. Journal of the American Society of Echocardiography. 2013;26(1):1-14.10.1016/j.echo.2012.10.00923140849
    Search in Google Scholar
DOI: https://doi.org/10.1515/amma-2015-0026 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 75 - 82
Submitted on: Dec 9, 2014
Accepted on: May 1, 2015
Published on: Aug 6, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
pulmonary arterial hypertension,
children
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 Şuteu Carmen, Blesneac Cristina, Togănel Rodica, Benedek Theodora, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 61 (2015): Issue 2 (June 2015)Next article